DSCM
NPCE icon

Divisadero Street Capital Management’s Neuropace NPCE Stock Holding History

Divisadero Street Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-292,792
Closed -$3.02M – 153
2025
Q3 		$3.02M Buy
292,792
+50,672
+21% +$478K 0.13% 96
2025
Q2 		$2.7M Buy
242,120
+203,640
+529% +$2.55M 0.17% 74
2025
Q1 		$473K Buy
+38,480
New +$482K 0.05% 78

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Divisadero Street Capital Management's NPCE Position: Q4 2025 in Review

Divisadero Street Capital Management sold out of Neuropace (NPCE) in Q4 2025, closing a stake of 292,792 shares — an estimated $3.02M sold.

Divisadero Street Capital Management first reported a position in NPCE in Q1 2025 and held it in 3 quarters. The position peaked at $3.02M in Q3 2025. 100 funds tracked by Wall St. Rank hold NPCE as of Q4 2025.

  • Divisadero Street Capital Management reported no remaining Neuropace position as of Q4 2025 after selling out during the quarter.
  • Divisadero Street Capital Management sold 292,792 Neuropace shares in Q4 2025, an estimated $3.02M.
  • Divisadero Street Capital Management first reported a position in Neuropace in Q1 2025 and held it in 3 quarters.
  • Divisadero Street Capital Management's Neuropace position peaked at $3.02M in Q3 2025.
  • 100 funds tracked by Wall St. Rank held Neuropace as of Q4 2025.

Based on Divisadero Street Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.